Women aged 21 to 65 years should have a Pap smear every 3 years, but those aged 30 to 65 years can wait 5 years if they also have an HPV test.
Advanced profiling of gene mutations in acute myeloid leukemia could potentially be used to help predict prognosis and guide treatment decisions.
A newly identified subtype of ovarian cancer that builds its own blood vessels may be vulnerable to agents that block blood vessel formation.
The majority of pregnant women with breast cancer can undergo surgery, chemotherapy, or both, but radiation therapy is generally not advised.
Another study has shown that human papillomavirus (HPV) testing of self-collected cervicovaginal specimens may be an effective way to screen more women for cervical cancer.
Researchers have discovered a rare but recurrent mutation that increases the risk of hereditary prostate cancer by up to 20 times.